Russell J. Schilder
- Reproductive Medicine top 0.2%
- Ovarian cancer diagnosis and treatment 70
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment 35
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers 15
- Obstetrics and Gynecology top 0.5%
- Endometrial and Cervical Cancer Treatments 25
- Genetics top 1%
-
- Lung Cancer Treatments and Mutations 22
-
- Monoclonal and Polyclonal Antibodies Research 17
-
- Intraperitoneal and Appendiceal Malignancies 11
-
- Cancer therapeutics and mechanisms 10
- Co-authors
- Lainie P. MartinThomas C. HamiltonAntonio J Grillo-LópezNalini JanakiramanChristine A. WhiteAndrew K. GodwinLeo I. GordonThomas E. Witzig
- Partner nations
- United StatesSpainCanada
In The Last Decade
Russell J. Schilder
149 papers receiving 7.8k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Reproductive Medicine 1.6k
- Pathology and Forensic Medicine 2.6k
- Oncology 3.3k
- Obstetrics and Gynecology 712
- Genetics 843
Countries citing papers authored by Russell J. Schilder
This map shows the geographic impact of Russell J. Schilder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell J. Schilder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell J. Schilder more than expected).
Fields of papers citing papers by Russell J. Schilder
This network shows the impact of papers produced by Russell J. Schilder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell J. Schilder. The network helps show where Russell J. Schilder may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Russell J. Schilder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 5 | |
| 4 | 2020 | 54 | |
| 5 | 2017 | 49 | |
| 6 | 2016 | 7 | |
| 7 | 2016 | 1 | |
| 8 | 2015 | 101 | |
| 9 | 2013 | 37 | |
| 10 | A PHASE 1B STUDY OF TREBANANIB (AMG 386) IN COMBINATION WITH PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) OR TOPOTECAN (T) IN WOMEN WITH RECURRENT OVARIAN CANCER | 2012 | 1 |
| 11 | 2012 | 24 | |
| 12 | 2008 | 41 | |
| 13 | 2007 | 136 | |
| 14 | 2007 | 4 | |
| 15 | 2004 | 3 | |
| 16 | 2004 | 29 | |
| 17 | 2004 | 24 | |
| 18 | 2000 | 10 | |
| 19 | 1999 | 2 | |
| 20 | Maximizing differences in the concanavalin A-induced blastogenic responses of lymphocytes from breast cancer patients and controls by the use of alpha-methyl-D-mannoside. | 1982 | 0 |
About Russell J. Schilder
Russell J. Schilder is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Pathology and Forensic Medicine, having authored 153 papers that have together received 7.9k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (70 papers), Lymphoma Diagnosis and Treatment (35 papers), Endometrial and Cervical Cancer Treatments (25 papers), Lung Cancer Treatments and Mutations (22 papers), Monoclonal and Polyclonal Antibodies Research (17 papers), Cancer Immunotherapy and Biomarkers (15 papers), Intraperitoneal and Appendiceal Malignancies (11 papers) and Cancer therapeutics and mechanisms (10 papers). The work is most often cited by research in Reproductive Medicine (1.6k citations), Pathology and Forensic Medicine (2.6k citations) and Oncology (3.3k citations). Russell J. Schilder has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Lainie P. Martin, Thomas C. Hamilton, Antonio J Grillo-López, Nalini Janakiraman, Christine A. White, Andrew K. Godwin, Leo I. Gordon, Thomas E. Witzig, Ivor Royston and B.K. Dallaire. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.